📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. (2016)

First Author: Mulenga V

Attributed to: Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(15)00319-9

PubMed Identifier: 26481928

Publication URI: http://europepmc.org/abstract/MED/26481928

Type: Journal Article/Review

Volume: 16

Parent Publication: The Lancet. Infectious diseases

Issue: 2

ISSN: 1473-3099